Cancer of the thyroid is relatively uncommon and represents less than 2-3 % of all incident cancers in many parts of the world.^[@r01],[@r02]^ Papillary carcinoma is the most common histological type and accounts for 50-80% of thyroid cancer cases while follicular carcinomas make up 10-40%. Highly fatal anaplastic carcinoma and non-epithelial medullary carcinoma are much less frequent.^[@r01]^ Exposure to ionizing radiation is a well-established cause of thyroid cancer, especially non-medullary carcinomas.^[@r01],[@r03]^ Recent evidence also implicates a history of goiter or thyroid nodules as a risk factor for thyroid cancer.^[@r04]^ Papillary carcinoma rates are higher in females than in males, especially at reproductive ages, suggesting a hormonal involvement.^[@r01]^ Ecological data suggest that papillary carcinomas tend to occur more frequently in areas of high iodine intake whereas follicular carcinomas occur more frequently in iodine-deficient areas.^[@r05]^ Several studies suggest a protective association of cigarette smoking, and of alcohol drinking less consistently, however.^[@r06]^

The incidence of thyroid cancer is relatively high in Japan,^[@r02]^ and is characterized by the predominance of papillary carcinomas.^[@r07]^ However, little is known about the etiology of thyroid cancer in Japan. In a hospital-based case-control study of female thyroid cancer, an increased risk was related to history of benign thyroid diseases and high parity while a decreased risk was related to Western style breakfast and coffee consumption.^[@r08]^ To our knowledge, no other Japanese study has investigated the association between lifestyle factors and thyroid cancer.

We conducted a case-control study of thyroid cancer in Hiroshima and Nagasaki to investigate a number of (potential) risk factors, including medical history, anthropometric factors, smoking and drinking habits, dietary habits, and female reproductive and menstrual factors, and to examine interaction between these factors and radiation exposure. Data on several specific risk factors from this study have been included in the international pooled analysis of 14 case-control studies of thyroid cancer.^[@r04],[@r06]^ The pooled analyses, however, only used a part of the data in each study area, and presented a brief summary on the methods.^[@r09]^ We carried out analyses of the entire dataset including all risk factors queried. The present paper provides information on study design and data collection in detail, and provides results regarding past medical history, family history, smoking and alcohol drinking. Most of the present results were not included in the previous pooled analyses, i.e., past history of non-thyroidal diseases; family history of cancer; smoking and alcohol drinking considering mutual confounding effects and interaction between the two factors; and possible effect modification by ionizing radiation exposure from the atomic bombings.

METHODS
=======

Subjects
--------

We initially identified incident thyroid cancer cases born in 1910 or later and diagnosed during 1970-1986 from the tumor registries in Hiroshima and Nagasaki.^[@r10]^ These registries provide population-based coverage of incident cancers occurring among the residents of Hiroshima and Nagasaki. Two pathologists (Y.H. and N.T.) reviewed 645 thyroid cancer cases for whom tumor pathology slides were available, and confirmed thyroid cancer in 528 (82%). We excluded 16 who had died before interview and 74 who were found to be living outside the tumor registry catchment areas. Interviews were attempted with the remaining 438 subjects and completed with 386 (88%).

Because population-based rosters or other means by which to identify control subjects in the community were not available for the present study, we selected controls from members of the Life Span Study or offspring (F1) cohort who were residing in the Hiroshima and Nagasaki areas at the time of this study. The Life Span Study cohort of over 120,000 persons was set up to study the late effects of radiation among atomic-bomb survivors.^[@r11]^ This cohort, however, includes a large number of persons (more than 57,000) with little or negligible radiation exposure, selected randomly from the Hiroshima/Nagasaki residents who were distally exposed to the atomic bombs or who were not in either city at the time of the bombings. The F1 cohort consists of 76,814 persons born to atomic-bomb survivors or controls.^[@r12]^ The two cohorts are being followed up by the Radiation Effects Research Foundation (RERF), and further cohort details are described elsewhere.^[@r11]-[@r13]^

For each thyroid cancer case born before 1945, one control was selected from members of the Life Span Study cohort, which includes only persons born before the atomic bombings in 1945. Controls were alive at the time of the study, had no history of cancer and were matched by city of residence, sex, year of birth, and atomic-bomb radiation exposure. For cases in the Life Span Study and their controls, the matching on radiation exposure was based on DS86 estimated dose (see below); for a case with "unknown dose", i.e., an exposed person for whom a dose estimate was not available, a control with unknown dose was selected. For cases born after 1945, controls were selected from members of the F1 cohort (born after 1945) by matching on city, sex and year of birth. Parental exposure to atomic bomb radiation was not considered in matching. Interviews were successfully completed for 87% of 522 controls.

The present analysis involved 362 papillary or follicular carcinoma case-control pairs. Excluded were cases who were 75 years old or over at the time of interview, and cases lacking an appropriate matched control. In addition, there were one anaplastic carcinoma case and two medullary carcinoma cases, and they were also excluded in the present analysis.

Measures
--------

Interviews were carried out between 1986 and 1988 by trained public health nurses who were not aware of the case-control status of the study subject. A pre-structured questionnaire was administered with 95% of the cases-control pairs while, for 5% of case-control pairs, surrogates (usually spouses) were interviewed. Questions were asked about histories regarding several specific thyroid condition, other diseases and radiotherapy to the head and neck region; family history of thyroid cancer and other cancer; anthropometric factors; lifestyle factors including smoking and alcohol drinking histories and dietary habits; and female reproductive and menstrual histories among women. Retrospective information was obtained up to the time of cancer diagnosis for cases, or up to the index time for controls. The index time for a control was when his/her counterpart case was diagnosed with thyroid cancer. Current smokers were those who regularly smoked cigarettes at the time of cancer diagnosis (or index time), and past smokers were those who had quit smoking before the time. As for alcohol drinking habits, consumption frequency at the time of cancer diagnosis (or index time) was queried for selected beverages, namely beer, sake, hard liquor, and whisky, with a pre-coded answer of "every day", "almost every day", "2-4 times per week", "once per week", "2-3 times per month", "once per month", "less than once per month", and "none". Persons drinking none of the beverages and those drinking any beverage every day were considered "never drinkers" and "daily drinkers", respectively. Persons other than never and daily drinkers were regarded as "non-daily drinkers".

For the Life Span Study subjects, individual radiation dose estimates were based on the dosimetry system DS86.^[@r14],[@r15]^ This system provides estimates of individual gamma-ray and neutron shielded kerma and organ doses based on information about a survivor's location and surrounding shielding conditions. We used the DS86 weighted thyroid dose, computed as gamma-ray dose plus ten times the neutron dose in units of sieverts (SV), to allow for the higher radiobiological effectiveness of neutrons compared to gamma-rays. By matching on radiation exposure, the main effect of radiation could not be assessed but a possible modification of other factors' effects by radiation exposure could be examined (as described below).

Statistical Analysis
--------------------

The associations between exposure factors and thyroid cancer risk were examined by estimating odds ratios (ORs) with corresponding 95% confidence intervals (CIs), as well as by testing a dose-response relationship if necessary, using a conditional logistic regression model. When there was no subject in either cases or controls for a given factor, the Fisher's exact test was applied. To examine whether the effect of a non-radiation factor is modified by atomic-bomb radiation exposure, case-control pairs were assigned an indicator variable for "exposed" (having dose 5+ mSv or unknown dose) or "non-exposed". Effect modification was tested by adding an interaction term (variable of interest multiplied by the indicator variable) to a model already containing variables for main effects other than radiation exposure. The trend test was carried out using a single variable coded as 1, 2 and 3 for smoking and alcohol drinking. Reported p-values were two-tailed, and a p-value of less than 0.05 was considered statistically significant. Statistical computations were done using the SAS^®^ software (Windows version release 9.1, Cary, the SAS institute).

RESULTS
=======

[Table 1](#tbl01){ref-type="table"} presents the distribution of cases by demographic variables, histology and atomic-bomb radiation dose. Two thirds were Hiroshima residents, and more than 90% had a histological diagnosis of papillary adenocarcinoma. The mean (range) of age at diagnosis was 43.0 (17-67) years. Only 57 cases (16%) were exposed to atomic bomb radiation, including 18 cases for whom the DS86 estimates were not available.^[@r14],[@r15]^ Duration from diagnosis to interview ranged between 2 and 17 years, with 2 years being the most frequent.

###### Characteristics of the thyroid cancer cases.

  Item                              n     \%
  --------------------------------- ----- ------
  City                                    
   Hiroshima                        247   68.2
   Nagasaki                         115   31.8
                                          
  Sex                                     
   Male                             57    15.7
   Female                           305   84.3
                                          
  Histology                               
   Papillary adenocarcinoma         335   92.5
   Follicular adenocarcinoma        27    7.5
                                          
  Age at diagnosis (year)                 
   \<30                             31    8.6
   30-39                            88    24.3
   40-49                            113   31.2
   50-59                            92    25.4
   60+                              38    10.5
                                          
  Calendar year of diagnosis              
   1970-1974                        36    9.9
   1975-1979                        108   29.8
   1980-1984                        149   41.2
   1985-1986                        69    19.1
                                          
  Atomic-bomb exposure                    
   Born after bombing               77    21.3
   Not exposed or negligible dose   228   63.0
   Exposed, 5-49 mSv                13    3.6
   Exposed, 50-499 mSv              14    3.9
   Exposed, 500+ mSv                12    3.3
   Exposed, unknown dose            18    5.0
                                          
  Total                             362   100

Because cases and controls were matched pair-wise on city, sex, age, and atomic-bomb exposure, corresponding figures for the controls were exactly the same as for the cases.

[Table 2](#tbl02){ref-type="table"} shows the association between thyroid cancer risk and selected past history and family history of cancer. A high proportion of the cases reported a prior history of goiter or thyroid nodule, resulting in a high OR estimate of 25 for goiter and 5 for nodule, respectively. By contrast, none of hyperthyroidism, hypothyroidism, or other thyroid disease was related to thyroid cancer risk. Five cases had undergone radiotherapy to the head and neck region while none of controls had (Fisher's exact test, p=0.062). Radiotherapy was given for treatment of goiter (three cases), hyperthyroidism (one case) and thyroid nodule (one case). No association with thyroid cancer was found for history of allergic conditions (asthma, urticaria, etc.), tonsillectomy, or regular use of diuretics or anti-hypertensive agents. Five cases had a family history of thyroid cancer among their parents or siblings (Fisher's exact test, p=0.062). Having a family history of any cancer was associated with a modest, but significantly increased OR. ORs were especially high for those with a family history of cancer among siblings (2.70) and among sisters (4.25).

###### Distribution of thyroid cancer cases and controls and corresponding odds ratios (OR) according to selected past history and family history.

  Variable                                                     Cases   Controls   OR (95% CI)\*
  ------------------------------------------------------------ ------- ---------- --------------------
  Disease of the thyroid gland                                                    
   Goiter                                                      25      1          25.00 (3.39-184.5)
   Nodule                                                      5       1          5.00 (0.58-42.8)
   Hyperthyroidism                                             4       5          0.80 (0.22-2.98)
   Hypothyroidism                                              2       1          2.00 (0.18-22.1)
   Other diseases                                              4       2          2.00 (0.37-10.9)
                                                                                  
  Radiotherapy to the head and neck region                     5       0          infinity
                                                                                  
  Allergic conditions                                                             
   Bronchial asthma                                            5       4          1.25 (0.34-4.66)
   Urticaria                                                   39      40         0.97 (0.60-1.57)
   Other allergic diseases                                     28      22         1.32 (0.73-2.39)
   Antihistamines regular use longer than one year             1       2          0.50 (0.05-5.51)
                                                                                  
  Other medical histories                                                         
   Tonsillectomy                                               5       4          1.25 (0.34-4.66)
   Diuretics regular use longer than one year                  3       5          0.60 (0.14-2.51)
   Anti-hypertensive agents regular use longer than one year   7       16         0.40 (0.16-1.03)
                                                                                  
  Family history of cancer                                                        
   Thyroid cancer, any first-degree relative                   5       0          infinity
   Any site, any first-degree relative                         93      68         1.48 (1.04-2.11)
   Any site, parent                                            70      58         1.24 (0.85-1.79)
   Any site, father                                            48      39         1.27 (0.81-1.98)
   Any site, mother                                            26      23         1.14 (0.64-2.02)
   Any site, sibling                                           28      11         2.70 (1.31-5.58)
   Any site, brother                                           11      6          1.83 (0.68-4.96)
   Any site, sister                                            18      5          4.25 (1.43-12.63)
   Any site, son                                               0       0          \-
   Any site, daughter                                          1       1          1.00 (0.06-15.99)

\* : Matched on city, age, sex, and radiation exposure

CI: confidence interval

[Table 3](#tbl03){ref-type="table"} shows thyroid cancer risk in association with smoking and alcohol drinking habits. Because smoking and alcohol drinking are closely correlated, the ORs for smoking were adjusted for alcohol consumption and the ORs for drinking were adjusted for smoking, as well as for family history of cancer (any site, any first-degree relative) and past history of thyroid nodules/goiter. The OR for thyroid cancer was significantly decreased for current cigarette smokers compared to those who never smoked. The higher OR for former smokers was not significant. The OR decreased significantly with the increasing number of cigarettes smoked per day. The OR tended to be lower for alcohol drinkers than that for nondrinkers. A dose-related response was suggested when the data were categorized by "never", "non-daily" and "daily" drinking. These relationships were consistent in the analyses repeated for men and women separately.

###### Distribution of thyroid cancer cases and controls and corresponding odds ratios (OR) according to cigarette smoking and alcohol drinking.

  Variable                                Cases   Controls   Adjusted OR\* (95% CI)
  ------------------ -------------------- ------- ---------- ------------------------
  Men and women                                              
  Smoking history    Never                292     271        1.00 (reference)
                     Past                 17      11         1.39 (0.58-3.34)
                     Current              53      80         0.46 (0.28-0.76)
                      ≤15 cig./d          24      30         0.53 (0.27-1.02)
                      16+ cig./d          24      43         0.33 (0.16-0.69)
                     p trend = 0.001^†^                      
                                                             
  Alcohol-drinking   Never                172     141        1.00 (reference)
                     Non-daily            155     167        0.75 (0.53-1.06)
                     Daily                35      54         0.59 (0.35-1.01)
                     p trend = 0.032                         
                                                             
  Men                                                        
  Smoking history    Never                14      9          1.00 (reference)
                     Past                 7       7          0.68 (0.14-3.39)
                     Current              36      41         0.57 (0.21-1.56)
                      ≤15 cig./d          10      9          0.46 (0.10-2.21)
                      16+ cig./d          21      28         0.53 (0.18-1.58)
                     p trend = 0.28^†^                       
                                                             
  Alcohol-drinking   Never                11      8          1.00 (reference)
                     Non-daily            37      25         1.18 (0.40-3.50)
                     Daily                9       24         0.37 (0.10-1.40)
                     p trend = 0.032                         
                                                             
  Women                                                      
  Smoking history    Never                278     262        1.00 (reference)
                     Past                 10      4          2.12 (0.64-6.98)
                     Current              17      39         0.38 (0.20-0.71)
                      ≤15 cig./d          14      21         0.54 (0.26-1.15)
                      16+ cig./d          3       15         0.19 (0.06-0.68)
                     p trend = 0.002^†^                      
                                                             
  Alcohol-drinking   Never                161     133        1.00 (reference)
                     Non-daily            118     142        0.67 (0.46-0.98)
                     Daily                26      30         0.83 (0.44-1.55)
                     p trend = 0.14                          

\* : Matched on city, age, sex, and radiation dose; adjusted for family history of cancer and past history of goiter or thyroid nodule; and mutually adjusted for smoking history (never, past, current) and alcohol drinking (never, non-daily, daily).

† : From never" to "current, ≤15 cigarettes/day" and "current, 16+ cigarettes/day".

CI: confidence interval

We examined the joint effect of smoking and drinking on the risk of thyroid cancer ([Table 4](#tbl04){ref-type="table"}). If the effects of smoking and drinking were additive, the OR for those who currently smoke and drink would be expected to be about 1 + (0.73-1) + (0.62-1) = 0.35, and if the effects were multiplicative the OR would be about 0.73 × 0.62 = 0.45. Both of these values were within the 95% CI of 0.14-0.50 for the OR estimate for those who currently smoke and drink. Formal tests for departures from the additive and multiplicative models gave p values of \>0.50 and 0.15, respectively. Thus, we could not reject either model.

###### Joint effect of smoking and drinking on the risk of thyroid cancer.

  Alcohol drinking   Smoking\*             
  ------------------ --------------------- -------------------
  Never              1.00 (reference)^†^   0.62 (0.27-1.41)
                     Ca : Co =146 : 115    Ca : Co = 15 : 15
                                           
  Current            0.73 (0.51-1.05)      0.26 (0.14-0.50)
                     Ca : Co = 141 : 147   Ca : Co = 33 : 58

\* : Pairs including a past smoker were deleted from analysis.

† : Odds ratio (95% confidence interval) matched on city, age, sex, and radiation dose, and adjusted for family history of cancer and past history of goiter or thyroid nodule.

Ca : number of cases

Co : number of controls

We repeated all of the above analyses in papillary adenocarcinoma case-control pairs, and found virtually same results (data not shown). [Table 5](#tbl05){ref-type="table"} shows the associations between thyroid cancer and selected non-radiation factors stratified by exposure to atomic-bomb radiation. There was no evidence of effect modification by radiation exposure on ORs associated with history of goiter/thyroid nodule, family history of cancer or cigarette-smoking. The OR associated with alcohol drinking was increased among the radiation-exposed group while it was decreased among the non-exposed, but this difference was of borderline significance (p=0.08).

###### Effect modification by radiation-exposure status on the association between non-radiation factors and thyroid cancer risk.

  Variable                     Non-exposed to radiation^§^          Exposed to radiation^¶^                                 
  ---------------------------- ------------------------------------ ------------------------- ------------------- ---- ---- ------------------
  History of goiter/nodule\*                                                                                                
   No                          280                                  304                       1.00 (reference)    52   56   1.00 (reference)
   Yes                         25                                   1                         25.9 (3.47-192.9)   5    1    3.75 (0.41-34.3)
                               *p* for effect modification = 0.20                                                           
                                                                                                                            
  Family history of cancer\*                                                                                                
   No                          235                                  255                       1.00 (reference)    34   39   1.00 (reference)
   Yes                         70                                   50                        1.55 (1.02-2.37)    23   18   1.43 (0.63-3.26)
                               *p* for effect modification = 0.70                                                           
                                                                                                                            
  Smoking^†^                                                                                                                
   Never                       244                                  226                       1.00 (reference)    48   45   1.00 (reference)
   Ever                        61                                   79                        0.57 (0.34-0.94)    9    12   0.45 (0.12-1.66)
                               *p* for effect modification = 0.99                                                           
                                                                                                                            
  Alcohol drinking^‡^                                                                                                       
   Never                       146                                  111                       1.00 (reference)    26   30   1.00 (reference)
   Ever                        159                                  194                       0.62 (0.43-0.89)    31   27   1.46 (0.62-3.42)
                               *p* for effect modification = 0.08                                                           

Matched on city, age, sex, and radiation dose; adjusted for history of goiter or nodule and family history of cancer; and additionally adjusted tor ^†^alcohol drinking (never, ever), ^‡^cigarette smoking (never, ever), or \*both.

§ : "Non-exposed" corresponds to "born after bombing" or "not exposed or negligible dose" of "atomic-bomb exposure" in [Table 1](#tbl01){ref-type="table"}

¶ : "exposed" corresponds to the other categories in [Table 1](#tbl01){ref-type="table"}.

OR: odds ratio

CI : confidence interval

DISCUSSION
==========

We analyzed medical history, family history, smoking, and alcohol drinking data from an epidemiologic study of thyroid cancer in which cases and controls were enrolled from a well-defined Japanese population. Thyroid cancer cases were ascertained from the population-based tumor registries in Hiroshima and Nagasaki,^[@r10]^ and controls were selected from the Life Span Study and F1 cohort populations by matching on demographic variables and on radiation exposure. The reference population is that of the Hiroshima and Nagasaki residents at the time of this study. Pre-structured personal interviews were conducted by trained public health nurses at the time of this study. Despite the low incidence of thyroid cancer,^[@r01],[@r02]^ the present study collected a fairly large number of cases, all of which were histologically confirmed by pathologists. In addition, the response rate was high and nearly identical for the cases (88%) and controls (87%). Although some of the data from this study were included in international pooled analyses,^[@r04],[@r06]^ the present analysis addressed specific questions not considered in the pooled analyses. We analyzed past medical history of non-thyroidal diseases; family history of cancer; smoking and alcohol drinking considering dose-response relationship, mutual confounding effects, and interaction between the factors. We also examined possible effect modification by radiation exposure, which is especially relevant for the population of Hiroshima and Nagasaki, although the small number (n=39) of case-control pairs for whom dose estimate was available did not allow a detailed analysis as previously done for breast cancer.^[@r16]^

The cases identified from the local population tumor registries included persons who had moved into Hiroshima or Nagasaki after the Life Span Study or F1 cohort was established decades before the present study while all controls were from one of the above cohorts. A potential selection bias may have occurred if thyroid cancer patients with certain characteristics, e.g., a history of goiter, a habit of smoking, etc., selectively moved to Hiroshima or Nagasaki. To assess the possible impact of such bias, we repeated analyses with 86 cases who were the members of the Life Span Study or F1 cohort and their counterpart controls. The results generally duplicated the findings based on all subjects. The point estimates of OR were 8.00 for history of goiter or thyroid nodule, 1.83 for history of any cancer in siblings, 2.00 for history of any cancer in sisters, 0.45 for current vs. never smokers, and 0.93 for daily vs. never drinkers, respectively.

Some of the thyroid cancer patients were prevalent cases, including those who had survived up to 17 years after diagnosis. Since patients with thyroid cancer, especially papillary adenocarcinoma or follicular adenocarcinoma, have excellent survival experience,^[@r17]^ use of prevalent cases would not be a significant source of selection bias, because attrition due to death, which would have been largely from causes other than thyroid cancer, is likely to have occurred almost equally among those with and without thyroid cancer. However, because smoking and alcohol drinking are generally considered "unhealthy", some cases may have quit these habits or reduced the amount and frequency of cigarette smoking or alcohol consumption after cancer diagnosis. The subjects in this study were asked about their habits before diagnosis (or index time), but it may have been difficult for them to recall the exact date of diagnosis for often dormant papillary/follicular carcinoma of the thyroid. We thus repeated the analysis of smoking and drinking with subjects to 182 case-control pairs in which the interview was carried out within 5 years after the index time. The results were similar to those based on all subjects. The OR for current smokers relative to nonsmokers adjusted for drinking was 0.41 (95% CI: 0.20-0.84), and the OR for daily drinkers relative to nondrinkers adjusted for smoking was 0.31 (95% CI: 0.13-0.72), adjusted as well for family history of cancer and past history of goiter/nodule.

The inverse association of thyroid cancer with smoking and alcohol drinking observed in the present study might have been confounded by factors that the present study could not consider. People with a high socioeconomic status or who highly care about their health are less likely to be a smoker or a heavy drinker, and also would be more sensitively aware of their bodily changes or more ready to visit a clinic, leading to a higher chance of thyroid cancer diagnosis. Such potential confounding bias associated with socioeconomic status or health consciousness may not be small for papillary adenocarcinoma of the thyroid gland, which is of a highly dormant and silent nature as indicated by a high prevalence rate (6-36 %) of latent papillary carcinoma at autopsy series.^[@r18]^

Although not all,^[@r19]-[@r22]^ several previous studies of thyroid cancer have reported a reduced risk of thyroid cancer significantly,^[@r23]-[@r26]^ or not significantly associated with cigarette smoking.^[@r27]-[@r33]^ Although results are less consistent,^[@r20],[@r22],[@r24],[@r29],[@r31]-[@r33]^ several studies have also suggested reduced thyroid cancer risk associated with alcohol drinking.^[@r19],[@r25],[@r27],[@r31],[@r34]^ A number of possible mechanisms have been suggested. Smoking may reduce thyroid-stimulating hormone (TSH) levels, which can promote thyroid hyperplasia leading to thyroid cancer.^[@r35],[@r36]^ Lower TSH levels in smokers than in former and never-smokers have been reported by some,^[@r37]-[@r40]^ but not all studies.^[@r41]^ Another proposed biological pathway is the anti-estrogenic effect of smoking.^[@r42]^ Estrogenic activity is thought to promote thyroid carcinogenesis. Although estrogen levels do not seem to be different between smokers and non-smokers,^[@r43]-[@r45]^ smoking may decrease the bioavailability of estrogens at target tissues.^[@r06],[@r46]-[@r48]^ Radiation exposure is considered to induce initial damage while hormonal changes due to smoking may be involved in a later stage of carcinogenesis, suggesting a possible multiplicative interaction. There was, however, no indication in the present data of a multiplicative interaction between smoking and radiation.

In the international pooled analysis, adjustment for current smoking eliminated an apparent protective effect of alcohol drinking.^[@r06]^ Rossing et al, however, reported a decreased risk of papillary thyroid cancer in women associated with alcohol consumption after controlling for smoking.^[@r34]^ In the present study, we found the significant effects of drinking after adjustment for smoking, and of smoking after adjustment for drinking. However, the findings are based on the relatively small number of subjects, and on crude measures of the intensity of alcohol consumption.

A strong association of thyroid cancer with a history of goiter or benign nodules has previously been reported.^[@r19],[@r24],[@r27],[@r29],[@r30],[@r49]-[@r51]^ Possible potential bias in reporting of previous thyroid disease by cases cannot be ruled out, but seems unlikely because the significantly elevated risk was specifically related to goiter or thyroid nodule but not to other thyroid diseases. Our OR estimated for goiter or nodule of 15.0 (95% CI: 3.6-62.7) is consistent with the estimates of 5.9 for a history of goiter and 29.9 for a history of benign nodules/adenomas as reported by Franceschi et al from the international pooled analysis which included our data.^[@r04]^ History of thyroid goiter and nodule is one of the strongest risk factors for thyroid cancer apart from radiation in childhood, although it remains unclear whether thyroid nodules are cancer precursor lesions or share a common etiologic background with thyroid cancer.

While several studies showed an increased risk of thyroid cancer linked to a family history of this cancer, the nature of the relationship between thyroid cancer and a family history of other cancers is not clear.^[@r52]^ We found five cases with a family history of thyroid cancer compared to none of the controls, but the difference was of borderline significance. We found a significantly increased OR associated with a cancer history in siblings, especially in sisters. The apparent relationships with family cancer history need to be interpreted carefully and potential recall bias in cancer cases must be considered. The generally high ORs associated with a history of cancer in any members of the family, including first-degree relatives, in our study tend to support the possibility of a potential recall bias by thyroid cancer patients.

Studies of the atomic bomb survivors and other irradiated populations have demonstrated a high risk of thyroid cancer associated with exposure in childhood and adolescence.^[@r01],[@r03]^ In the present study, the proportion and number of cases exposed to the atomic bombs at age 20 years or younger were small. Therefore, the lack of a significant interaction between radiation exposure and nonradiation factors, such as history of goiter/nodule, family history of cancer, smoking, and alcohol drinking, may be due to insufficient statistical power.

Recently attention has been given to an increasing trend of thyroid cancer in the United States^[@r53]^ and other countries.^[@r54],[@r55]^ Increasing trend of thyroid cancer was also observed previously in Japan,^[@r56]^ although updated analysis of thyroid cancer trends is desirable. The increasing trend may in part be attributed to improved diagnosis or detection but also reflect changes in risk factors. The latest worldwide cancer incidence data also indicate that thyroid cancer rates are high in Japan as well as in Australia, New Zealand, and Central America.^[@r02]^ Studies of risk factors in populations with high thyroid cancer rates may provide useful insights into possible risk determinants. The present analysis focused on medical history, family history, smoking and alcohol drinking in the case-control study to examine a variety of possible risk factors. Results of analyses of other factors will be forthcoming. The present paper showed that history of goiter or thyroid nodule is a significant risk factor for thyroid cancer in Japan as in other countries. The apparent association with family history of thyroid and other cancer suggests host susceptibility, either genetic or otherwise, but is uncertain due to the limitations with self-reported retrospective information, and needs corroboration by others using different methods. Cigarette smoking was found to reduce thyroid cancer risk and alcohol drinking may also have a protective effect independent of smoking. The inverse relationship between these two factors and thyroid cancer is strange in view of the finding that smokers have increased risk of other thyroid pathologies, such as goiter and nodules,^[@r57],[@r58]^ which predispose individuals with these conditions to an increased risk of thyroid cancer. In addition to learning more about the hormonal and other biological effects of smoking and drinking, further epidemiologic research is needed to clarify the nature of the inverse association with smoking and drinking, as prospective data available to date^[@r20],[@r22]^ have failed to confirm this association. Thyroid cancer is relatively infrequent and less fatal than most other malignancies, but presents a significant morbidity burden in the community and warrants more epidemiologic attention than previously given.
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